
Farhana Akhter Hoque
Examiner (ID: 4129, Phone: (571)270-7543 , Office: P/2866 )
| Most Active Art Unit | 2866 |
| Art Unit(s) | 2858, 2831, 2866 |
| Total Applications | 1162 |
| Issued Applications | 970 |
| Pending Applications | 81 |
| Abandoned Applications | 132 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16329903
[patent_doc_number] => 20200300869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => CIRCULATING ANGIOPOIETIN-2 (ANG-2) AND INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 7 (IGFBP7) FOR THE PREDICTION OF STROKE
[patent_app_type] => utility
[patent_app_number] => 16/899629
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13318
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899629
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/899629 | Circulating Angiopoietin-2 (Ang-2) and insulin-like growth factor-binding protein 7 (IGFBP7) for the prediction of stroke | Jun 11, 2020 | Issued |
Array
(
[id] => 16313798
[patent_doc_number] => 20200292536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => SYNTHETIC CONTROLS FOR IMMUNOHISTOCHEMISTRY
[patent_app_type] => utility
[patent_app_number] => 16/888252
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -70
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16888252
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/888252 | Synthetic controls for immunohistochemistry | May 28, 2020 | Issued |
Array
(
[id] => 17777901
[patent_doc_number] => 20220244251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => Targets and Methods of Diagnosing and Monitoring Lyme Disease
[patent_app_type] => utility
[patent_app_number] => 17/614168
[patent_app_country] => US
[patent_app_date] => 2020-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16035
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614168
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/614168 | Targets and Methods of Diagnosing and Monitoring Lyme Disease | May 26, 2020 | Pending |
Array
(
[id] => 16329771
[patent_doc_number] => 20200300737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => SAMPLE PREPARATION AND SPECIFIC CAPTURE FOR MULTIPLEX DETECTION OF TARGET ANALYTES (i.e., BACTERIA, VIRUSES, ETC.)
[patent_app_type] => utility
[patent_app_number] => 16/880844
[patent_app_country] => US
[patent_app_date] => 2020-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16880844
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/880844 | SAMPLE PREPARATION AND SPECIFIC CAPTURE FOR MULTIPLEX DETECTION OF TARGET ANALYTES (i.e., BACTERIA, VIRUSES, ETC.) | May 20, 2020 | Abandoned |
Array
(
[id] => 16270183
[patent_doc_number] => 20200271670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => BIOMARKERS FOR RISK ASSESSMENT AND TREATMENT MONITORING IN HEART FAILURE PATIENTS GUIDED BY NATRIURETIC PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/868644
[patent_app_country] => US
[patent_app_date] => 2020-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27849
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16868644
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/868644 | Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides | May 6, 2020 | Issued |
Array
(
[id] => 16254794
[patent_doc_number] => 20200264168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => DETECTION OF ALLERGENS USING SURFACE-ENHANCED RAMAN SCATTERING
[patent_app_type] => utility
[patent_app_number] => 16/868189
[patent_app_country] => US
[patent_app_date] => 2020-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5571
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16868189
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/868189 | Detection of allergens using surface-enhanced raman scattering | May 5, 2020 | Issued |
Array
(
[id] => 17898397
[patent_doc_number] => 20220308059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => BIOMARKERS FOR DISEASE PROGRESSION IN SQUAMOUS CELL CARCINOMA
[patent_app_type] => utility
[patent_app_number] => 17/594939
[patent_app_country] => US
[patent_app_date] => 2020-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15325
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594939
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594939 | BIOMARKERS FOR DISEASE PROGRESSION IN SQUAMOUS CELL CARCINOMA | Apr 30, 2020 | Abandoned |
Array
(
[id] => 16469583
[patent_doc_number] => 20200371120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/849492
[patent_app_country] => US
[patent_app_date] => 2020-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16849492
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/849492 | Diagnosis and treatment of autoimmune diseases | Apr 14, 2020 | Issued |
Array
(
[id] => 16207891
[patent_doc_number] => 20200240881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => ENCAPSULATED REAGENTS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/847343
[patent_app_country] => US
[patent_app_date] => 2020-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16847343
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/847343 | Encapsulated reagents and methods of use | Apr 12, 2020 | Issued |
Array
(
[id] => 17143030
[patent_doc_number] => 20210311043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => METHOD FOR DETERMINING A LECTIN-BINDING GLYCAN INDICATIVE TO TRAUMATIC BRAIN INJURY
[patent_app_type] => utility
[patent_app_number] => 16/840931
[patent_app_country] => US
[patent_app_date] => 2020-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16840931
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/840931 | METHOD FOR DETERMINING A LECTIN-BINDING GLYCAN INDICATIVE TO TRAUMATIC BRAIN INJURY | Apr 5, 2020 | Abandoned |
Array
(
[id] => 20310193
[patent_doc_number] => 20250327822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-23
[patent_title] => COMPANION DIAGNOSTIC ASSAY FOR GLOBO-H RELATED CANCER THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/595830
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595830
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/595830 | COMPANION DIAGNOSTIC ASSAY FOR GLOBO-H RELATED CANCER THERAPY | Mar 26, 2020 | Pending |
Array
(
[id] => 17658461
[patent_doc_number] => 20220178926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => A METHOD FOR DETERMINING THE LIKELIHOOD OF A PATIENT BEING RESPONSIVE TO CANCER IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/602757
[patent_app_country] => US
[patent_app_date] => 2020-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13937
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602757
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/602757 | A METHOD FOR DETERMINING THE LIKELIHOOD OF A PATIENT BEING RESPONSIVE TO CANCER IMMUNOTHERAPY | Mar 19, 2020 | Pending |
Array
(
[id] => 16159217
[patent_doc_number] => 20200217841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => IN VITRO METHOD FOR THE DETERMINATION OF NEURODEGENERATIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/823620
[patent_app_country] => US
[patent_app_date] => 2020-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823620
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823620 | IN VITRO METHOD FOR THE DETERMINATION OF NEURODEGENERATIVE DISEASES | Mar 18, 2020 | Abandoned |
Array
(
[id] => 16114415
[patent_doc_number] => 20200209230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => METHODS AND COMPOSITIONS RELATING TO SMALL MOLECULE ANALYTE ASSAYS
[patent_app_type] => utility
[patent_app_number] => 16/814296
[patent_app_country] => US
[patent_app_date] => 2020-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11510
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 243
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16814296
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/814296 | METHODS AND COMPOSITIONS RELATING TO SMALL MOLECULE ANALYTE ASSAYS | Mar 9, 2020 | Abandoned |
Array
(
[id] => 16284755
[patent_doc_number] => 20200278357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => METHODS FOR PREDICTING MAJOR ADVERSE CARDIOVASCULAR EVENTS IN SUBJECTS WITH CORONARY ARTERY DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/805136
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24480
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16805136
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/805136 | Methods for predicting major adverse cardiovascular events in subjects with coronary artery disease | Feb 27, 2020 | Issued |
Array
(
[id] => 20674116
[patent_doc_number] => 12614637
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-28
[patent_title] => In vitro method for predicting mortality risk in patients suffering from shock
[patent_app_type] => utility
[patent_app_number] => 17/432038
[patent_app_country] => US
[patent_app_date] => 2020-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 13
[patent_no_of_words] => 2963
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17432038
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/432038 | In vitro method for predicting mortality risk in patients suffering from shock | Feb 19, 2020 | Issued |
Array
(
[id] => 17483636
[patent_doc_number] => 20220091140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => METHOD OF DIAGNOSIS
[patent_app_type] => utility
[patent_app_number] => 17/431637
[patent_app_country] => US
[patent_app_date] => 2020-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5585
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17431637
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/431637 | METHOD OF DIAGNOSIS | Feb 16, 2020 | Pending |
Array
(
[id] => 18169781
[patent_doc_number] => 20230036392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => COMPOSITIONS AND METHODS TO DETECT GASTROINTESTINAL DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/428416
[patent_app_country] => US
[patent_app_date] => 2020-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428416
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/428416 | Compositions and methods to detect gastrointestinal disease | Feb 3, 2020 | Issued |
Array
(
[id] => 17596955
[patent_doc_number] => 20220146529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => IMMUNOASSAY METHOD FOR FREE AIM IN BIOLOGICAL SAMPLE
[patent_app_type] => utility
[patent_app_number] => 17/427209
[patent_app_country] => US
[patent_app_date] => 2020-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7777
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17427209
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/427209 | IMMUNOASSAY METHOD FOR FREE AIM IN BIOLOGICAL SAMPLE | Jan 29, 2020 | Abandoned |
Array
(
[id] => 20716403
[patent_doc_number] => 12631645
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-19
[patent_title] => Detection of BCL-2 family heterodimer complexes and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/422972
[patent_app_country] => US
[patent_app_date] => 2020-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 25
[patent_no_of_words] => 9158
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422972
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/422972 | Detection of BCL-2 family heterodimer complexes and use thereof | Jan 28, 2020 | Issued |